Marpai, Inc. (MRAI) Form 10-Q — Nov 12, 2026
Marpai's Q3 2026 10-Q discloses substantial doubt about its ability to continue as a going concern, with just $360 thousand of unrestricted cash, $5.5 million of negative working capital, and $11.1 million of net loss on nine-month revenue of $13.0 million. The company funded itself via a $12.1 million Series A preferred stock offering in July 2026, a $2.0 million vendor financing advance, and CEO loans, but remains heavily leveraged with $18.8 million owed to AXA (10% compounding interest) and $7.6 million of convertible debentures.
Key figures
- Revenue
- 4424000
- Total Debt
- 24400000
- Revenue Yoy
- Q3 +9.6%; nine months -7.6%
- Total Assets
- 10812000
- Cash Position
- 360000
- Shares Outstanding
- 26915941
- Axa liability
- 18764000
- Restricted cash
- 7411000
- Accumulated deficit
- 126446000
- Net loss nine months
- 11052000
- Preferred dividend rate
- 8% cumulative
- Common stock equivalents
- 23016333
- Negative working capital
- 5500000
- Vendor financing advance
- 2000000
- Convertible debentures net
- 7586000
- Preferred offering gross proceeds
- 12100000
- Operating cash outflow nine months
- 11557000
AI analysis
Red flags7 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.